Case Study: Landscape of Chimeric RNAs in Bladder Cancer

Area of Science:

• Oncology
• Genomics
• Bioinformatics

Background:

• Chimeric RNAs are implicated in various cancers, serving as potential biomarkers and therapeutic targets.
• Understanding chimeric RNA profiles is crucial for advancing cancer diagnostics and treatment.

Purpose of the Study:

• To map the landscape of chimeric RNAs in bladder cancer.
• To identify and validate specific fusion transcripts associated with bladder cancer.
• To investigate the mechanism and cellular localization of a novel bladder cancer-associated chimeric RNA.

Main Methods:

• Bioinformatic analysis of The Cancer Genome Atlas (TCGA) bladder urothelial carcinoma RNA-sequencing dataset (414 cancer, 19 normal samples).
• Application of stringent criteria to identify high-confidence chimeric RNAs, including cancer-specific ones.
• Validation of selected chimeric RNAs in clinical bladder cancer samples using molecular techniques.
• Investigation of the biogenesis (cis-splicing between adjacent genes - cis-SAGe) and subcellular localization of CHFR-GOLGA3.

Main Results:

• Identification of 19,547 chimeric RNAs, refined to 271 high-confidence candidates, with 13 specifically expressed in cancer.
• Validation of 6 chimeric RNAs in clinical samples.
• Significant upregulation of CHFR-GOLGA3 in bladder cancer compared to normal samples.
• Determination that CHFR-GOLGA3 is produced via cis-SAGe and primarily localized in the nucleus, suggesting non-coding function.

Conclusions:

• The study establishes a comprehensive chimeric RNA landscape for bladder cancer.
• CHFR-GOLGA3 is a validated, cancer-specific chimeric RNA potentially acting as a non-coding RNA.
• The findings provide a strategic framework for chimeric RNA research in other tumor types.